Tags

Type your tag names separated by a space and hit enter

Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
Am J Gastroenterol. 1984 Feb; 79(2):143-9.AJ

Abstract

Plasma glucagon, insulin and glucose concentrations, and liver function tests were determined after an overnight fast in 24 normal subjects and 50 male cirrhotic patients. In cirrhotic patients with normal liver profiles, plasma glucagon remained within normal limits, irrespective of the presence of portasystemic anastomoses either pathological or surgical. Hyperglucagonemia was documented in presence of advanced liver dysfunction alone. Significant correlations were established between plasma glucagon and several liver function tests, i.e., serum bilirubin, albumin/globulin ratio, and prothrombin time. Moreover, hyperglucagonemia normalized on recovery from clinical manifestations and improvement in liver profile. Plasma insulin was raised primarily in the presence of a significant portasystemic shunting and maximum levels were observed in patients manifesting advanced liver dysfunction as well. However, no correlation was evident between plasma insulin and any of the liver function tests. Fasting plasma glucose was not altered in cirrhotic patients. Therefore, it is concluded that in hepatic cirrhosis, glucagon secretion by pancreatic alpha-cell may be dependent on the severity of the hepatocellular damage whereas portasystemic shunting may be responsible for hyperinsulinemia which may be further exaggerated in presence of advanced liver dysfunction.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

Language

eng

PubMed ID

6364796

Citation

Kabadi, U M., et al. "Hyperglucagonemia in Hepatic Cirrhosis: Its Relation to Hepatocellular Dysfunction and Normalization On Recovery." The American Journal of Gastroenterology, vol. 79, no. 2, 1984, pp. 143-9.
Kabadi UM, Eisenstein AB, Tucci J, et al. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery. Am J Gastroenterol. 1984;79(2):143-9.
Kabadi, U. M., Eisenstein, A. B., Tucci, J., & Pellicone, J. (1984). Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery. The American Journal of Gastroenterology, 79(2), 143-9.
Kabadi UM, et al. Hyperglucagonemia in Hepatic Cirrhosis: Its Relation to Hepatocellular Dysfunction and Normalization On Recovery. Am J Gastroenterol. 1984;79(2):143-9. PubMed PMID: 6364796.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery. AU - Kabadi,U M, AU - Eisenstein,A B, AU - Tucci,J, AU - Pellicone,J, PY - 1984/2/1/pubmed PY - 1984/2/1/medline PY - 1984/2/1/entrez SP - 143 EP - 9 JF - The American journal of gastroenterology JO - Am J Gastroenterol VL - 79 IS - 2 N2 - Plasma glucagon, insulin and glucose concentrations, and liver function tests were determined after an overnight fast in 24 normal subjects and 50 male cirrhotic patients. In cirrhotic patients with normal liver profiles, plasma glucagon remained within normal limits, irrespective of the presence of portasystemic anastomoses either pathological or surgical. Hyperglucagonemia was documented in presence of advanced liver dysfunction alone. Significant correlations were established between plasma glucagon and several liver function tests, i.e., serum bilirubin, albumin/globulin ratio, and prothrombin time. Moreover, hyperglucagonemia normalized on recovery from clinical manifestations and improvement in liver profile. Plasma insulin was raised primarily in the presence of a significant portasystemic shunting and maximum levels were observed in patients manifesting advanced liver dysfunction as well. However, no correlation was evident between plasma insulin and any of the liver function tests. Fasting plasma glucose was not altered in cirrhotic patients. Therefore, it is concluded that in hepatic cirrhosis, glucagon secretion by pancreatic alpha-cell may be dependent on the severity of the hepatocellular damage whereas portasystemic shunting may be responsible for hyperinsulinemia which may be further exaggerated in presence of advanced liver dysfunction. SN - 0002-9270 UR - https://www.unboundmedicine.com/medline/citation/6364796/Hyperglucagonemia_in_hepatic_cirrhosis:_its_relation_to_hepatocellular_dysfunction_and_normalization_on_recovery_ L2 - https://medlineplus.gov/cirrhosis.html DB - PRIME DP - Unbound Medicine ER -